Citation Impact
Citing Papers
Chronic Q fever endocarditis causing massive splenomegaly and hypersplenism.
1982
Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data
1997 Standout
Clinical experience with beta adrenergic blocking agents in myocardial ischaemia: A dilemma and a challenge
1981
Pregnancy and Cardiovascular Disease
1977
Q fever—a review and issues for the next century
1997
Q Fever 1985-1998: Clinical and Epidemiologic Features of 1,383 Infections
2000
Glomerular Nephropathy Associated With Chronic Q Fever
1988
Effect of Atenolol on Mortality and Cardiovascular Morbidity after Noncardiac Surgery
1996 Standout
Q fever in Europe: Current aspects of aetiology, epidemiology, human infection, diagnosis and therapy
1987
Mutations of theConnexin43Gap-Junction Gene in Patients with Heart Malformations and Defects of Laterality
1995
Cardiac rupture, mortality and the timing of thrombolytic therapy: A meta-analysis
1990
Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis
2006 Standout
Q fever vaccines: Present status and application in man
1987
Q Fever in the Greek Island of Crete: Epidemiologic, Clinical, and Therapeutic Data from 98 Cases
1995
Coxiella burnetii (Q Fever) Pneumonia
1995
Botulinum Toxin as a Biological Weapon
2001 Standout
Q Fever Endocarditis in Israel and a Worldwide Review
1997
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Immunohistologic demonstration of coxiella burnetii in the valves of patients with Q fever endocarditis
1994
Thyroid Hormone and the Cardiovascular System
2001 Standout
The Role of Lipopolysaccharides in the Virulence of Coxiella burnetii
1990
Q-fever and autoimmunity
1989
The relationship between heart rate, heart rate variability and depression in patients with coronary artery disease
1988
Treatment of Q Fever Endocarditis
1999
Q Fever: Current Concepts
1987
Chronic Q fever. Ninety-two cases from France, including 27 cases without endocarditis
1993
Coxiella burnetii Infection of Aneurysms or Vascular Grafts: Report of Seven Cases and Review
1998
Q Fever Meningoencephalitis in a Soldier Returning from the Persian Gulf War
1993
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial
2002 Standout
Randomized, Controlled Trials, Observational Studies, and the Hierarchy of Research Designs
2000 Standout
The Gap Junction Communication Channel
1996 Standout
Clinical recognition and management of patients exposed to biological warfare agents
1997
A Guinea Pig Model for Q Fever Endocarditis
1998
Connexin 26 mutations in hereditary non-syndromic sensorineural deafness
1997 StandoutNature
Infective endocarditis
2004 Standout
Quantifying heterogeneity in a meta‐analysis
2002 Standout
Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter
1989
Bias in meta-analysis detected by a simple, graphical test
1997 Standout
Antihypertensive Treatment and Secondary Prevention of Cardiovascular Disease Events Among Persons Without Hypertension
2011
Personality as independent predictor of long-term mortality in patients with coronary heart disease
1996 Standout
Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration
1994 Standout
Cellular Immunity in Q Fever: Specific Lymphocyte Unresponsiveness in Q Fever Endocarditis
1985
Phosphorylation of the Inhibitor Component of Troponin by Phosphorylase Kinase
1972 StandoutNobel
Q Fever Endocarditis in the United States
1979
Q fever endocarditis
1982
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
1994 Standout
Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials
2003 Standout
Failure of rifampicin and co-trimoxazole in Q fever endocarditis.
1982
Diagnosis of Q Fever
1998
Inefficacy of digitalis in the control of heart rate in patients with chronic atrial fibrillation: Beneficial effect of an added beta adrenergic blocking agent
1979
Enzyme-linked immunosorbent assay for diagnosis of chronic Q fever
1988
Adenyl Cyclase and Cyclic AMP
1971
Modification of the diagnostic criteria proposed by the duke endocarditis service to permit improved diagnosis of q fever endocarditis
1996
Analysis of influence of catecholamine and tachycardia during supine exercise in patients with mitral stenosis and sinus rhythm.
1969
Treatment of Q fever
1993
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
An outbreak of Q fever affecting postal workers in Oxfordshire
1987
Isolated Hormone Receptors
1973 StandoutNobel
Lipopolysaccharide variation in Coxiella burnetti: intrastrain heterogeneity in structure and antigenicity
1985
Q-FEVER ENDOCARDITIS IN ENGLAND AND WALES, 1975-81
1982
Biochemical and physiologic effects of thyroid hormone on cardiac performance
1983
Depression Following Myocardial Infarction
1993 Standout
Q Fever Endocarditis on Porcine Bioprosthetic Valves
1988
Coronary Thrombolysis for Evolving Myocardial Infarction
1984
Q fever endocarditis: diagnostic approaches and monitoring of therapeutic effects
1992
Clinical Q fever in Northern Ireland 1962-1989.
1990
Evaluating the federal role in financing health-related research
1996 StandoutNobel
Changes in circulating immune complex concentrations and antibody titres during treatment of Q fever endocarditis.
1985
In vitro susceptibilities of Coxiella burnetii, Rickettsia rickettsii, and Rickettsia conorii to the fluoroquinolone sparfloxacin
1991
Importance of heart rate in determining beta-blocker efficacy in acute and long-term acute myocardial infarction intervention trials
1986
Modulation by the thyroid state of intracellular calcium and contractility in ferret ventricular muscle.
1988 StandoutNobel
Q Fever
1999 Standout
Detection and Persistence of Specific IgM Antibody to Coxiella burnetii by Enzyme-Linked Immunosorbent Assay: A Comparison with Immunofluorescence and Complement Fixation Tests
1983
A trial of propranolol in myocardial infarction.
1968
Q FEVER PNEUMONIA ASSOCIATED WITH EXPOSURE TO WILD RABBITS
1986
Immediate haemodynamic effects of a beta adrenergic blocking agent-propranolol-in mitral stenosis at fixed heart rates.
1972
Catecholamine sensitivity, thyroid hormone and the heart
1971
Thyroid hormone regulation of beta-adrenergic receptor number.
1977 StandoutNobel
Q fever endocarditis of porcine xenograft valves
1983
ACC/AHA 2006 Guidelines for the Management of Patients With Valvular Heart Disease
2006 Standout
Specific Binding of β-Adrenergic Catecholamines to a Subcellular Fraction from Cardiac Muscle
1973 StandoutNobel
Abnormal Left Ventricular Function in Hyperthyroidism
1982
Antigenic variation in the phase I lipopolysaccharide of Coxiella burnetii isolates
1986
ABSENCE OF PROPHYLACTIC EFFECT OF PROPRANOLOL IN MYOCARDIAL INFARCTION
1966
A Fraction of the Ventricular Myocardium That Has the Specificity of the Cardiac Beta-Adrenergic Receptor
1971 StandoutNobel
Comparison of different antibiotic regimens for therapy of 32 cases of Q fever endocarditis
1991
Chronic Q fever associated with granulomatous hepatitis
1984
Blood pressure, stroke, and coronary heart disease
1990 Standout
Influence of the Thyroid State on the Intrinsic Contractile Properties and Energy Stores of the Myocardium*
1967
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
2014 Standout
Comparison of enzyme-linked immunosorbent assay and complement fixation and indirect fluorescent-antibody tests for detection of Coxiella burnetii antibody
1987
Antibiotic susceptibilities of two Coxiella burnetii isolates implicated in distinct clinical syndromes
1989
The Enhanced Myocardial Contractility of Thyrotoxicosis
1971
Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data
2000 Standout
Beta blockade during and after myocardial infarction: An overview of the randomized trials
1985 Standout
Coronary Plaque Disruption
1995 Standout
Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction.
1983
Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
2000 Standout
CONTROLLED TRIAL OF SOTALOL FOR ONE YEAR AFTER MYOCARDIAL INFARCTION
1982
EFFECT ON MORTALITY OF METOPROLOL IN ACUTE MYOCARDIAL INFARCTION
1981
Q Fever Hepatitis
1982
The clinical importance of cardioselectivity and lipophilicity in beta blockers
1980
Epidemiologic Features of Chronic Atrial Fibrillation
1982 Standout
Activation of cardiac adenyl cyclase by thyroid hormone
1968
Treatment with Histamine H2Antagonists in Acute Upper Gastrointestinal Hemorrhage
1985 Standout
Direct Binding Studies of Adrenergic Receptors: Biochemical, Physiologic, and Clinical Implications
1979 StandoutNobel
Characterization of a phase I Coxiella burnetii chloroform-methanol residue vaccine that induces active immunity against Q fever in C57BL/10 ScN mice
1986
Shell-vial assay: evaluation of a new technique for determining antibiotic susceptibility, tested in 13 isolates of Coxiella burnetii
1991
EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION
1986 Standout
Chronic Q fever endocarditis.
1980
Endocarditis Due to Rare and Fastidious Bacteria
2001 Standout
Purification and Characterization of a Protein Inhibitor of Adenosine 3',5'-Monophosphate-dependent Protein Kinases
1971 StandoutNobel
Fate of phase I and phase II Coxiella burnetii in several macrophage-like tumor cell lines
1981
Serological evaluation of O fever in humans: enhanced phase I titers of immunoglobulins G and A are diagnostic for Q fever endocarditis
1983
A Long-Term Prevention Study with Oxprenolol in Coronary Heart Disease
1982
Biological and immunological properties of Coxiella burnetii vaccines in C57BL/10ScN endotoxin-nonresponder mice
1982
Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii
2007 Standout
Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts
1982 Standout
Secondary prevention after myocardial infarction: A review of long-term trials
1982
Conducting Meta-Analyses inRwith themetaforPackage
2010 Standout
Serological diagnosis of Q fever endocarditis
1986
Effect of Intravenous Streptokinase on Acute Myocardial Infarction
1982
Isolation of Coxiella burnetii from heart valves of patients treated for Q fever endocarditis
1995
Endocarditis Due to Q Fever in Nova Scotia: Experience with Five Patients in 1981-1982
1983
Vitamin E Supplementation and Cardiovascular Events in High-Risk Patients
2000 Standout
Relation of Left Atrial Pathology to Atrial Fibrillation in Mitral Valvular Disease
1968
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial
2002 Standout
Cellular Mechanisms of Atrial Contractile Dysfunction Caused by Sustained Atrial Tachycardia
1998
Adenyl Cyclase and Myocardial Contractility
1970
Effects of Beta Blockade on the Peripheral Manifestations of Thyrotoxicosis
1971
One year's treatment with propranolol after myocardial infarction: preliminary report of Norwegian multicentre trial.
1982
Complexity and contradiction in clinical trial research
1987
2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
2019 Standout
Q-fever endocarditis.
1985
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol
2002 Standout
Meta-analysis in clinical trials
1986 Standout
Influence of Pituitary, Thyroid, and Adrenal Hormones on Norepinephrine Turnover and Metabolismin the Rat Heart
1968 StandoutNobel
Identification of the Cardiac Beta-Adrenergic Receptor Protein: Solubilization and Purification by Affinity Chromatography
1972 StandoutNobel
Works of G. Howitt being referenced
Streptokinase in acute myocardial infarction: a controlled multicentre study in the United Kingdom.
1976
Atrial function after cardioversion
1967
Propranolol (Inderal) in Disturbances of Cardiac Rhythm
1965
Myocardial contractility, and the effects of beta-adrenergic blockade in hypothyroidism and hyperthyroidism.
1968
Eisenmenger Syndrome in Pregnancy
1965
Chronic Q Fever
1976
THE EFFECT OF PRONETHALOL IN MITRAL STENOSIS.
1965
BETA-SYMPATHETIC BLOCKADE IN HYPERTHYROIDISM
1966
ATRIAL SEPTAL DEFECT IN THREE GENERATIONS
1961
Multicentre post-infarction trial of propranolol in 49 hospitals in the United Kingdom, Italy, and Yugoslavia.
1980
Propranolol as ocular hypotensive agent.
1967
The heart in hyperthyroidism
1967